An award-winning journalist and New York Times best-selling author, David Faber is a co-anchor of CNBC's "Squawk on the Street" (M-F: 9 a.m.-12 p.m. ET) and an anchor and co-producer of CNBC's acclaimed original documentaries and long-form programming.
During the day, Faber breaks news and provides in-depth analysis on a range of business topics during the "Faber Report." In his 20 years with CNBC, Faber has broken many big financial stories including the massive fraud at WorldCom, the bailout of the hedge fund Long Term Capital Management and Rupert Murdoch's unsolicited bid for Dow Jones.
Faber has reported ten documentaries for CNBC for which he has received Loeb, Emmy, Peabody and duPont awards.
His book, "The Faber Report," was published by Little, Brown in spring 2002; his second book, "And Then the Roof Caved In," was published in the summer of 2009 by John Wiley.
He holds a bachelor's degree in English from Tufts University.
Follow David Faber on Twitter
Investors in Emergency Medical Services Corp. are scratching their heads with one hand and calling their lawyers with the other as they try to understand how the company paid $300 million in “transaction costs” for its $3.2 billion leveraged buyout and why those costs were included in the purchase price.
After a week’s delay, senior executives at UBS’s U.S. investment bank are getting a fresh look Wednesday at the size of the bonus pool they will divvy up for their employees.
UBS's bonus pool for 2010 was so small as to be termed “unworkable” by a number of senior executives at the bank, and the payout has now been delayed as pleas are made to the UBS board for the pool to be increased, according to people familiar with the situation.
Genzyme and Sanofi-Aventis have reached a so called “agreement in principle” for a deal in which Sanofi will acquire Genzyme.
I thought Barry Sternlicht's, chairman and CEO of Starwood Capital Group, comment about the quickening race upward in commercial real estate values is one worth noting.